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ABSTRACT: Small-molecule ﬂuorescent sensors are versatile agents
for detecting mobile zinc in biology. Capitalizing on the abundance of
validated mobile zinc probes, we devised a strategy for repurposing
existing intensity-based sensors for quantitative applications. Using
solid-phase peptide synthesis, we conjugated a zinc-sensitive Zinpyr-1
derivative and a zinc-insensitive 7-hydroxycoumarin derivative onto
opposite ends of a rigid P9K peptide scaﬀold to create HcZ9, a
ratiometric ﬂuorescent probe for mobile zinc. A plate reader-based
assay using HcZ9 was developed, the accuracy of which is comparable
to that of atomic absorption spectroscopy. We investigated zinc
accumulation in prostatic cells and zinc levels in human seminal ﬂuid.
When normal and tumorigenic cells are bathed in zinc-enriched
media, cellular mobile zinc is buﬀered and changes slightly, but total
zinc levels increase signiﬁcantly. Quantiﬁcation of mobile and total zinc levels in human seminal plasma revealed that the two are
positively correlated with a Pearson’s coeﬃcient of 0.73.
Zinc is an essential nutrient in biology.1 Most biological zincions are tightly bound to proteins, functioning as catalytic
or structural cofactors. In contrast, a small percentage of zinc is
weakly bound to endogenous ligands and considered chelatable
or mobile.2−4 Mobile forms of zinc occur throughout the body
and are capable of producing unique “zinc signals” critical to
physiological functions of the endocrine/exocrine, immune,
nervous, and reproductive systems.5−8
In the reproductive system, zinc is linked to male fertility,5,6
oocyte maturation,9 and cancer.10−12 The healthy prostate
contains large stores of zinc within the epithelium of the
peripheral zone.6 Zinc is released from secretory granules
within epithelial cells into prostatic ﬂuid, which comprises up to
30% of the volume of seminal ﬂuid.6,13,14 High zinc levels in
seminal ﬂuid enhance fertility by facilitating spermatozoa
release from semenogelin proteins and promoting subsequent
motility.5,15 In cancerous prostate tissue, zinc levels are
signiﬁcantly reduced.6,10 This reduction in zinc is not associated
with adenoma or carcinoma but is found near sites of
inﬂammation.8,10,16,17 These observations suggest that zinc is
intimately involved with oncogenesis, and if inﬂammation may
be ruled out or treated, zinc could be used as a cancer-speciﬁc
biomarker.10,17 Understanding the physiology of prostatic zinc
requires tools that can rapidly detect and quantify mobile zinc
in complex environments such as cell lysate and biological
ﬂuids.
Fluorescent sensors are eﬀective agents for investigating zinc
biology.3,18,19 Most zinc sensors consist of small-molecule
ﬂuorescent reporters derivatized with zinc-binding units.
Extensive exploration in this ﬁeld has yielded an array of
small-molecule zinc probes with diverse photophysical and
zinc-binding properties that have been validated in live cells,
tissues, and animals.3,18,19 Probes such as Fluozin-3, Newport
Green, and Zinpyr-1 are intensity-based and increase in
brightness (εϕ) upon binding Zn2+ ions. Despite their utility,
the inability to extract quantitative information using these
probes is a major limitation.19
Ratiometric sensors oﬀer a means to quantify mobile zinc
concentration. The ratiometric response, R, is deﬁned as the
ratio of the emission intensity at two diﬀerent wavelengths. In
contrast to single-wavelength measurements from intensity-
based sensors, R from dual-wavelength experiments is less
sensitive to photobleaching and heterogeneous sample
composition, which can globally alter the ﬂuorescence intensity
and lead to errors in the data or its misinterpretation. Although
a number of ratiometric zinc sensors have been reported, we
ﬁnd relatively few instances of small-molecule sensors being
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used to quantify mobile zinc in biological solutions.19 Complex
syntheses, small dynamic ranges, and narrow gaps between the
wavelengths used to determine R might be responsible for the
limited application of these small-molecule ratiometric sensors
in quantifying mobile zinc.
To overcome these challenges, we developed a synthetic
strategy that uses solid-phase peptide synthesis to construct
ratiometric zinc sensors. By coupling an intensity-based zinc
probe to a zinc-insensitive ﬂuorophore through a rigid
polyproline spacer, we created a modular two-ﬂuorophore
assembly in which the zinc-sensitive and -insensitive units can
be selected for speciﬁc applications. Similar small-molecule,
two-ﬂuorophore cassettes for ratiometric sensing have been
developed for a variety of analytes, including zinc.20−22 Most
two-ﬂuorophore systems that detect zinc, however, employ
ﬂexible linkers, which fail to separate the two ﬂuorophores
adequately and result in diminished photophysical proper-
ties.20−23 Incorporation of a polyproline helix in our linker
provides suﬃcient rigidity to our two-ﬂuorophore system while,
at the same time, exploiting the ease and modularity of solid-
phase peptide synthesis.
As a proof-of-concept, we synthesized and characterized
HcZ9, which joins a Zinpyr-1 (ZP1) derivative and a 7-
hydroxycoumarin (Hc) derivative through a 10-residue peptide,
P9K (Figure 1). A mobile zinc assay using HcZ9 was developed
that is compatible with standard ﬂuorescence plate readers and
quantiﬁes zinc with accuracy comparable to that of zinc atomic
absorption spectroscopy (AAS). Unlike zinc AAS, however,
HcZ9 is selective for mobile zinc. In addition, the mobile zinc
assay is much faster than current zinc AAS technology. HcZ9
was successfully applied to two case studies: (1) monitoring the
change in mobile zinc levels when normal and malignant
prostatic epithelial cells are bathed in zinc-enriched medium
and (2) assessing the correlation between mobile zinc and total
zinc in human seminal ﬂuid. The results of these studies are
presented here.
From the suite of existing intensity-based zinc sensors, green
emitting 5-CO2H-ZP1 was selected as the zinc-sensitive
ﬂuorophore for its brightness, subnanomolar zinc-binding
aﬃnity, and compatibility with solid-phase peptide syn-
thesis.24,25 5-CO2H-ZP1 is a representative member of the
Zinpyr family of zinc sensors, which have zinc dissociation
constants (Kd‑Zn) that span several orders of magnitude and
have been extensively validated in living systems.3 For the zinc-
insensitive probe, we chose 7-hydroxycoumarin-3-carboxylic
acid, a small, water-soluble ﬂuorophore with a high ﬂuorescence
quantum yield, as well as absorption and emission bands that
are distinct from those of ZP1. To separate the two
ﬂuorophores, we prepared a 10-residue (∼31 Å) polyproline
peptide with the sequence P9K. Polyproline peptides adopt
rigid secondary structures that make them eﬀective spacers for
two-ﬂuorophore systems.26 The nine-residue polyproline motif
was selected after an initial screen, which included three- and
six-residue polyproline sequences.
The P9K peptide was synthesized using standard Fmoc-based
chemistry. With orthogonal protecting groups, we sequentially
added the Hc and ZP1 moiety to the N-terminus and C-
terminal lysine side chain, respectively, to aﬀord the resulting
construct, Hc-P9K(ZP1)-CONH2, abbreviated as HcZ9 (Figure
1, Supplemental Figure S1). In addition, two singly labeled
peptides, Hc-P9K and P9K(ZP1), were prepared to further
probe the photophysical properties of HcZ9 (Supplemental
Figure S2).
The zinc-binding and photophysical properties of HcZ9 were
measured in buﬀer (50 mM PIPES and 100 mM KCl, pH 7)
and are summarized in Supplemental Table S1. The absorption
spectrum (Supplemental Figure S3) shows two principal
maxima at 396 and 521 nm, which are assigned to the Hc
and ZP1 moieties, respectively (Supplemental Figures S4 and
Figure 1. Representation of HcZ9, which features a 7-hydroxycoumar-
in derivative appended to the N-terminus of a peptide having the
sequence P9K. A Zinpyr-1 derivative is coupled to the side chain of the
C-terminal lysine residue.
Figure 2. HcZ9 responds to zinc with a ratiometric change in ﬂuorescence intensity. (a) Zinc-induced ﬂuorescence enhancement of HcZ9. The zinc-
insensitive Hc ﬂuorophore is excited (λex: 360 nm) and its ﬂuorescence spectrum recorded (blue trace; λem: 400−495 nm). Separately, the ZP1
moiety is excited (λex: 485 nm) and the ﬂuorescence spectrum recorded (green trace; λem: 495−650 nm). (b) A representative calibration curve. The
linear regions correspond to the ﬁrst (red line) and second (green line) equivalents of Zn2+ binding to ZP1, respectively, and ﬁnally stoichiometric
saturation of the sensor (blue line). (c) Standard solutions of Zn(NO3)2 were analyzed using AAS and the HcZ9. The linear ﬁt shows a slope of 0.94
± 0.07 and a linear correlation coeﬃcient of R2 = 0.98. Data are means ± SE.
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S5). Circular dichroism spectroscopy suggests that HcZ9
adopts a polyproline type II helix conformation in aqueous
buﬀer (Supplemental Figure S6).27 Although HCZ9 can be
used as a FRET-based sensor (Supplementary Figures S3−S5),
independently exciting each ﬂuorophore on HcZ9 increases the
signal-to-background ratio, is compatible with a standard
ﬂuorescence plate reader, and reduces the eﬀect of conforma-
tional changes due to interactions with biomolecules on the
activity of the sensor. When HcZ9 operates as a dual-excitation,
dual-emission sensor, the increase in the ratio of integrated
ﬂuorescence intensity, R, upon addition of excess ZnCl2 is 5.3-
fold. Here, we deﬁne the ratio, R, as R = FZP1/FHc, where FZP1 is
the integrated emission intensity for ZP1 (λex: 485 nm; λem:
495−650 nm) and FHc is the integrated emission intensity for
Hc (λex: 360 nm; λem: 365−495 nm) (Figure 2a). HcZ9 was
titrated with zinc in the presence of Ca-EDTA, a zinc buﬀering
agent, to demonstrate mobile zinc detection and to determine
an apparent zinc dissociation constant (Kd‑Zn) for HcZ9 of 0.12
± 0.01 nM (Supplemental Figure S8).3 The ratiometric
response is also selective for Zn2+ over other biologically
relevant divalent metal ions (Supplemental Figure S9)
Following validation of the ratiometric zinc response of
HcZ9, we developed an assay for mobile zinc. Developing
quantitative assays for mobile zinc in complex biological
material will improve our understanding of zinc biology.
Members of the Zinpyr family have been used to devise a
ﬂuorometric assay for mobile zinc,28−30 but without ratiometric
output these intensity-based sensors can be prone to artifacts.
HcZ9, in contrast, oﬀers the sensitivity and selectivity of the
Zinpyr family but with the added advantage of ratiometric
output.
For high-throughput analysis, the HcZ9-based mobile zinc
assay was developed in a standard 96-well microplate format. A
calibration curve was constructed by titrating a 1 μM solution
of HcZ9 in buﬀer (50 mM PIPES and 100 mM KCl, pH 7)
with an equal volume of standard zinc solutions. R is calculated
from the ﬂuorescence intensities, normalized, and plotted
against total zinc concentration (Figure 2b). The resulting
binding isotherm can be ﬁt to three linear regions.31 The ﬁrst
region corresponds to the formation of Zn:HcZ9 and leads to a
response that is ∼20% of the maximal dynamic range. The
second linear region correlates to the formation of Zn2:HcZ9
and yields a ratiometric response equal to ∼80% of maximal
dynamic range. The third region occurs when the sensor is
saturated with zinc and additional zinc ions will not further
increase the ﬂuorescence response.
Peptide-based compounds can be unstable in biological
samples; however, HcZ9 was shown to exhibit suﬃcient
stability under the assay conditions using ﬂuorometric and
HPLC methods (Supplemental Figure S10). To determine the
accuracy of the mobile zinc assay, we prepared a series of
standard zinc solutions and measured their zinc content using
both Zn AAS and the HcZ9 probe (Figure 2c). Both techniques
yielded similar results, indicating that the mobile zinc assay and
zinc AAS have comparable accuracy (Figure 2c). The mobile
zinc assay, however, oﬀers several advantages over zinc AAS.
HcZ9 selectively detects mobile zinc, whereas zinc AAS
monitors total zinc. Moreover, our assay does not require
expensive equipment, such as an AAS or related instrument, but
instead employs more readily available ﬂuorescence plate
readers.
After conﬁrmation that HcZ9 accurately measures mobile
zinc concentrations under controlled conditions, we inves-
tigated its performance in cell lysates. For cell lines, we chose
RWPE-1 and -2, PC-3, and HeLa. Spike and recovery
experiments were performed to assess the accuracy of the
method. In a typical experiment, the mobile zinc levels are
measured before and after an addition of 250 nM (0.5 equiv)
Figure 3. Mobile and total zinc measurements of cell lysates. (a) The mobile zinc concentration of cell lysate was measured before and after the
addition of 250 nM (0.5 equiv) of ZnCl2. The measured increase in mobile zinc is shown in nM and compared to the expected increase (%
recovery). (b) RWPE-1 and RWPE-2 cells were bathed for 30 min in either unmodiﬁed KSFM (gray bars) or KSFM supplemented with 10 μM zinc
pyrithione (ZnPT) (red bars). (c) Mobile and (d) total zinc concentrations in RWPE-1 and RWPE-2 cells were measured after cells were bathed for
24 h in either unmodiﬁed KSFM (gray bars) or in KSFM supplemented with 50 μM ZnCl2 (blue bars). The measured mobile zinc concentration is
calculated relative to protein content. Data for total zinc in the RWPE cells were adapted from ref 28. Data are means ± SE; n.s. is not signiﬁcant; *p
< 0.05; **p ≪ 0.01.
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ZnCl2. In all cell lines, the amount of spiked zinc measured was
within 10% of the expected value (Figure 3a), suggesting that
the activity of HcZ9 is not signiﬁcantly altered by various
biomolecules in these biological samples and validating the
ability of HcZ9 to quantify mobile zinc in cell lysates
(Supplemental Figure S11).
To study whether HcZ9 can measure changes in intracellular
mobile zinc concentrations, cells were incubated for 30 min
with 10 μM zinc pyrithione (ZnPT), a membrane-permeable
metal complex that rapidly delivers zinc into the cell.32 After
treatment with ZnPT, the resulting lysates showed a signiﬁcant
increase in mobile zinc levels (Figure 3, Supplemental Figure
S10). Furthermore, the lysates also had a signiﬁcant increase in
total zinc (Supplemental Figure S12). Notably, the increase in
total zinc was much greater than the increase in mobile zinc. In
the RWPE cell lines, for example, treatment with ZnPT resulted
in an increase of 3 μg total Zn per mg protein, whereas the
mobile zinc levels only increased by approximately 0.3 μg of Zn
per mg of protein. These results reveal that the cells can
eﬀectively buﬀer mobile zinc levels even when challenged with
a large bolus of external zinc over a short period of time (Figure
3 and Supplemental Figure S12).
After validating the mobile zinc assay in cell lysates, we
examined the relationship between total zinc and mobile zinc in
prostatic cells. The RWPE lines represent a pair of genetically
similar prostatic epithelial cells. RWPE-2 cells, however, express
the v-Ki-ras oncogene and are tumorigenic.
33 RWPE-2 cells also
have altered zinc traﬃcking pathways. Together, the RWPE
lines have been used as model systems for investigating zinc
biology in prostate cancer.34,35 To monitor zinc accumulation,
RWPE-1 and -2 cells were incubated for 24 h in either normal
keratinocyte serum-free medium (KSFM) or KSFM supple-
mented with a total [ZnCl2] = 50 μM. We specify total zinc
because, owing to the buﬀer capacity of complete medium,28
the available amount of mobile zinc is most likely less than 50
μM. Mirroring the results with ZnPT addition treatment, both
cell lines showed signiﬁcant accumulation of total zinc but
much smaller increases in mobile zinc (Figure 3c). We do note
that by analyzing cell lysates, our reported values for mobile
zinc content represent an average of all subcellular compart-
ments; thus, any information regarding zinc traﬃcking
pathways is lost. Given its facile nature and accuracy, however,
our mobile zinc assay should prove useful in studying these
levels in complex ﬂuids or tissues at the cellular level.
To further demonstrate the utility of HcZ9, we measured
total and mobile zinc in human seminal ﬂuid. Evidence suggests
that zinc in prostatic ﬂuid correlates with prostate cancer, and it
has been identiﬁed as a potential biomarker for the disease.10
Moreover, mobile zinc levels have been directly linked to sperm
motility and function.6,14 There is a need for a rapid, accurate,
and selective assay for mobile zinc in human seminal ﬂuid.
We measured the mobile and total zinc content in seminal
plasma from 107 prostate cancer patients that took part in a
clinical study testing the eﬀects of diet modiﬁcation on prostate
biology.36 Prior work suggests that, after secretion, as much as
50% of zinc is redistributed and sequestered by medium and
high molecular weight compounds from seminal vesicles.13 Our
data reveal a positive correlation (Pearson’s r = 0.73) between
total and mobile zinc levels in seminal ﬂuid (Figure 4).
Interestingly, the correlation appears weaker at high zinc levels;
further studies are needed to conﬁrm and understand the
apparent breakdown in the correlation at higher zinc levels.
In summary, we synthesized and characterized HcZ9, a
peptide-based, ratiometric sensor for quantifying mobile zinc in
biological solutions. Using HcZ9, a high-throughput mobile
zinc assay was developed with comparable accuracy to zinc
AAS. Our assay was applied to quantifying mobile zinc in
epithelial prostatic cells and showed that both normal and
tumorigenic cells maintain buﬀered mobile zinc levels even
when challenged with exogenous zinc. In addition, HcZ9 was
used to measure mobile zinc levels in human seminal plasma,
revealing a positive correlation between the total and mobile
zinc levels. The mobile zinc assay can be used with a variety of
biological samples, such as homegenized tissue or organelle
extracts, which would yield insight into changes in zinc
homeostasis under diﬀerent conditions. We envision that our
synthetic strategy can generate ratiometric sensors for other of
analytes, which would expand the chemical toolkit for
determining concentrations of analytes in biological material.
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